<div class="container">

<table style="width: 100%;"><tr>
<td>df</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>JAMA Breast cancer</h2>

<h3>Description</h3>

<p>A dataset containing predictions for chemo-censitivity and pathological response 
from Hatzis (2011)
</p>


<h3>Usage</h3>

<pre><code class="language-R">data(df)
</code></pre>


<h3>Details</h3>


<ul>
<li>
<p> validate: Validation status
</p>
</li>
<li>
<p> drfs: Censoring status; 0=censored, 1=event.
</p>
</li>
<li>
<p> drfs.time: Time to event or censoring
</p>
</li>
<li>
<p> er.status: ER status, P=positive, N=negative
</p>
</li>
<li>
<p> chemo.pred: Prediction for chemo sensitivity from the ACES predictor, sensitive or insensitive
</p>
</li>
<li>
<p> pre.N: Prediction of nodal status
</p>
</li>
<li>
<p> pCR.RD: pathological complete response (pCR) or residual disease (RD) 
</p>
</li>
<li>
<p> pre.grade: prediction of tumor grade
</p>
</li>
<li>
<p> pre.T: T stage prediction
</p>
</li>
<li>
<p> dlda30: DLDA30 prediction for the pathological response.
</p>
</li>
</ul>
<h3>References</h3>

<p>[1] Hatzis, C., Pusztai, L., Valero, V., Booser, D. J., Esserman, L., Lluch, A., et al. (2011). A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. The Journal of the American Medical Association 305, 1873â€“1881.
</p>


</div>